Lung function abnormal in sickle cell anemia
Posted on: Friday, 16 June 2006, 22:30 CDT
NEW YORK (Reuters Health) - Ninety percent of adults with sickle cell anemia have abnormal lung function tests, according to a report in the American Journal of Respiratory and Critical Care Medicine.
Sickle cell anemia is a hereditary disease in which red blood cells assume a sickle shape when body oxygen levels run low. This sets up a vicious circle, because the sickle cells do not efficiently deliver oxygen, leading to the formation of more sickle cells. Severe pain and life-threatening complications can arise during these sickle crises.
Lung complications are common for sickle cell patients, but few large studies have characterized the occurrence of abnormal lung function tests in this population, lead author Dr. Elizabeth S. Klings, from Boston University School of Medicine, and colleagues note.
In the present study, lung function tests from 310 adults with sickle cell anemia were analyzed and correlated with sickle cell complications. Just 10 percent of patients had completely normal tests, the report indicates.
The most common type of abnormality was a reduction in the lung's ability to expand. In addition, gases did not pass across lung tissue as easily as they do in healthy subjects.
Greater understanding of the use of lung function tests in sickle cell patients is important because it could lead to a better understanding of how shortness of breath and low blood oxygen levels arise in these patients, they add.
SOURCE: American Journal of Respiratory and Critical Care Medicine, June 1, 2006.
Source: REUTERS
Related Articles
- Lung cells used for sensing antigens
- Ohio State University Medical Center to Test Efficacy of Hyperbaric Oxygen Medicine on Stroke Victims
- Study in the Annals of Internal Medicine Finds Patients Suffering From Sickle Cell Anemia in Much Worse Pain Than Previously Thought
- Stem Cells Used to Cure Sickle-Cell Anemia in Mice
- Software to Help in Sickle Cell Anemia
- Sickle Cell Anemia, the History Behind the Disease
- Icagen Reports Results of Phase II Open Label Extension Study of ICA-17043 for the Treatment of Sickle Cell Anemia
- New Ways to Prevent Stroke and Reduce Excess Iron in Sickle Cell Anemia
- Lung Cells Made in Test Tube May Help Transplants
User Comments (0)

RSS Feeds